相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism
Yuhua Zhao et al.
CANCER RESEARCH (2011)
Cell Signaling by Receptor Tyrosine Kinases
Mark A. Lemmon et al.
CELL (2010)
Phosphate-induced Apoptosis of Hypertrophic Chondrocytes Is Associated with a Decrease in Mitochondrial Membrane Potential and Is Dependent upon Erk1/2 Phosphorylation
Susanne U. Miedlich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells
Shumin Zhang et al.
MOLECULAR CANCER (2010)
Importing Mitochondrial Proteins: Machineries and Mechanisms
Agnieszka Chacinska et al.
CELL (2009)
Nuclear Translocation of the Epidermal Growth Factor Receptor Family Membrane Tyrosine Kinase Receptors
Shao-Chun Wang et al.
CLINICAL CANCER RESEARCH (2009)
Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth
Y. H. Zhao et al.
ONCOGENE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Survival of cancer cells is maintained by EGFR independent of its kinase activity
Zhang Weihua et al.
CANCER CELL (2008)
Tumor cell metabolism: Cancer's Achilles' heel
Guido Kroemer et al.
CANCER CELL (2008)
Cancer cell metabolism: Warburg and beyond
Peggy P. Hsu et al.
CELL (2008)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Localization of PTP-1B, SHP-2, and Src exclusively in rat brain mitochondria and functional consequences
Amal Arachiche et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Src-tyrosine kinases are major agents in mitochondrial tyrosine phosphorylation
Elena Tibaldi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Causes and consequences of increased glucose metabolism of cancers
Robert J. Gillies et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c
Allyson E. Vaughn et al.
NATURE CELL BIOLOGY (2008)
ErbB receptors: from oncogenes to targeted cancer therapies
Hongtao Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The Warburg effect and its cancer therapeutic implications
Zhao Chen et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2007)
Glycolysis in cancer: A potential target for therapy
Robert A. Gatenby et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Cancer's molecular sweet tooth and the Warburg effect
Jung-whan Kim et al.
CANCER RESEARCH (2006)
Mitochondria as therapeutic targets for cancer chemotherapy
L. Galluzzi et al.
ONCOGENE (2006)
Upregulation and activation of PKCα by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKCa and Src inhibitors
M. Tan et al.
ONCOGENE (2006)
Protein kinase PKC delta and c-Abl are required for mitochondrial apoptosis induction by genotoxic stress in the absence of p53, p73 and Fas receptor
Malika Lasfer et al.
FEBS LETTERS (2006)
Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide
M Tan et al.
CANCER RESEARCH (2006)
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
Valeria R. Fantin et al.
CANCER CELL (2006)
ErbB2 promotes Src synthesis and stability: Novel mechanisms of Src activation that confer breast cancer metastasis
M Tan et al.
CANCER RESEARCH (2005)
Inhibition of ErbB2 causes mitochondrial dysfunction in cardiornyocytes - Implications for herceptin-induced cardiomyopathy
LP Grazette et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin
CD Austin et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers
XY Zhou et al.
CLINICAL CANCER RESEARCH (2004)
Regulation of cytochrome c oxidase activity by c-Src in osteoclasts
T Miyazaki et al.
JOURNAL OF CELL BIOLOGY (2003)
Induction or suppression of expression of cytochrome C oxidase subunit II by heregulin β 1 in human mammary epithelial cells is dependent on the levels of ErbB2 expression
YB Sun et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
Phosphorylation on tyrosine-15 of p34Cdc2 by ErbB2 inhibits p34Cdc2 activation and is involved in resistance to taxol-induced apoptosis
M Tan et al.
MOLECULAR CELL (2002)
Mitochondrial PKCε and MAPK form signaling modules in the murine heart -: Enhanced mitochondrial PKCε-MAPK interactions and differential MAPK activation in PKCε-induced cardioprotection
CP Baines et al.
CIRCULATION RESEARCH (2002)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
分享论文
